Data Set Core Medata Schema 2.16.840.1.113883.3.1937.777.64.1.2

A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A part of a study [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

Data encoded in a defined structure [DataCite (https://doi.org/10.14454/3w3z-sa82)].

The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A written description of a change(s) to, or formal clarification of, a protocol [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A document describing the data, including metadata, and their meaning, usage, and relationship to other data [NFDI4Health].

A template of a document explaining all the relevant information to assist an individual in understanding the expectations and risks in making a decision about a procedure. This document is presented to and signed by the individual or guardian [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

(1) A document that informs the patient about procedures, potential risks or side effects of a proposed medication or operation; (2) A document that informs the patient about data being collected [NFDI4Health].

Detailed, written instructions to achieve uniformity of the performance of a specific function [EMA (European Medicines Agency - ICH: E 6 (R2): Guideline for good clinical practice - Step 5 (europa.eu))].

A document that contains a more technical and detailed elaboration of the principal features of the analysis described in the protocol, and includes detailed procedures for executing the statistical analysis of the primary and secondary variables and other data [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A document that addresses the overall data management process [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health].

A printed, optical, or electronic document designed to record all of the clinical study-required information stipulated in the protocol to be reported to the sponsor on each clinical trial subject [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

Pre-defined categorization scheme used for content coding, a data collection technique to transform qualitative data (textual, video, audio or still-image) originally produced for other purposes into quantitative data [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)].

Set of pre-determined questions presented to study participants [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)].

Themes, topics, and/or questions used in an interview. Can vary between loosely defined themes to more exactly formulated questions. There is more flexibility than in an unstructured questionnaire regarding which questions are asked of each participant and how they are conveyed [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)].

Guidelines (i.e., directions or instructions regarding the methods and procedures to be used for collecting the data) regarding what will be observed. Depending on the study design, an observation guide can be more or less structured, ranging from exact specifications and scales to loosely formulated ideas [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)].

Guidelines (i.e., directions or instructions regarding the methods and procedures to be used for collecting the data) for a group discussion. Depending on the study design, a discussion guide can be more or less structured, ranging from exactly formulated questions to general ideas on what to discuss. For example, a list of topics to be discussed in a focus group, or themes formulated by a researcher to direct a blog discussion, etc. [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)].

A description of tasks that participants are asked to carry out as a part of the data collection process. For example, marking places on a map, taking photographs, telling a fairy tale, etc. [DDI (https://ddialliance.org/Specification/DDI-CV/TypeOfInstrument_1.1.html)]. 

A data collection instrument that is not covered by any of the other values in this list [NFDI4Health].

A study document that is not covered by any of the other values in this list [NFDI4Health].

A resource that is not covered by any of the other values in this list [NFDI4Health, DataCite (https://doi.org/10.14454/3w3z-sa82)].

A series of visual representations imparting an impression of motion when shown in succession. May or may not include sound. For example, films, video, etc. [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A medium for recording information in the form of writing or images, typically composed of many pages bound together and protected by a cover [DataCite (https://doi.org/10.14454/3w3z-sa82)].

One of the main divisions of a book [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An aggregation of resources, which may encompass collections of one Resource Type as well as those of mixed types. A collection is described as a group; its parts may also be separately described.  For example, a collection of samples, or various files making up a report [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A virtual notebook environment used for literate programming [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Article that is written with the goal of being accepted to a conference [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Collection of academic papers published in the context of an academic conference [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A factual and objective publication with a focused intent to identify and describe specific data, sets of data, or data collections to facilitate discoverability [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Data encoded in a defined structure [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A written essay, treatise, or thesis, especially one written by a candidate for the degree of Doctor of Philosophy [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A non-persistent, time-based occurrence [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A visual representation other than text. For example, digitised or born digital images, drawings or photographs [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A resource requiring interaction from the user to be understood, executed, or experienced. For example, training modules, files that require use of a viewer (e.g., Flash), or query/response portals [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A scholarly publication consisting of articles that is published regularly throughout the year [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A written composition on a topic of interest, which forms a separate part of a journal [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An abstract, conceptual, graphical, mathematical or visualization model that represents empirical objects, phenomena, or physical processes [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A formal document that outlines how research outputs are to be handled both during a research project and after the project is completed. For example, data management plan [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Evaluation of scientific, academic, or professional work by others working in the same field [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An inanimate, three dimensional object or substance. For example, artifacts, specimens [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A version of a scholarly or scientific paper that precedes formal peer review and publication in a peer-reviewed scholarly or scientific journal [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A document that presents information in an organized format for a specific audience and purpose [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An organized system of apparatus, appliances, staff, etc., for supplying some function(s) required by end users. For example, data management service, or long-term preservation service [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A computer program other than a computational notebook, in either source code (text) or compiled form. Use this type for general software components supporting scholarly research. Use the “Computational Notebook” value for virtual notebooks [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A resource primarily intended to be heard. For example, audio recording [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Something established by authority, custom, or general consent as a model, example, or point of reference [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A resource consisting primarily of words for reading that is not covered by any other textual resource type in this list [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A structured series of steps which can be executed to produce a final outcome, allowing users a means to specify and enact their work in a more reproducible manner [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A resource that is not covered by any of the other values in this list [DataCite (https://doi.org/10.14454/3w3z-sa82)].

This license allows re-users to distribute, remix, adapt, and build upon the material in any medium or format, with no conditions. It is a public dedication tool, which allows creators to give up their copyright and put their works into the worldwide public domain. For more details, visit https://creativecommons.org/publicdomain/zero/1.0/ [Creative Commons (https://creativecommons.org/about/cclicenses/)].

This license allows re-users to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. For more details, visit https://creativecommons.org/licenses/by/4.0/ [Creative Commons (https://creativecommons.org/about/cclicenses/)].

This license allows re-users to distribute, remix, adapt, and build upon the material in any medium or format for non-commercial purposes only, and only so long as attribution is given to the creator. For more details, visit https://creativecommons.org/licenses/by-nc/4.0/ [Creative Commons (https://creativecommons.org/about/cclicenses/)].

The license allows re-users to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.  For more details, visit https://creativecommons.org/licenses/by-sa/4.0/ [Creative Commons (https://creativecommons.org/about/cclicenses/)].

The license allows re-users to distribute, remix, adapt, and build upon the material in any medium or format for non-commercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.  For more details, visit https://creativecommons.org/licenses/by-nc-sa/4.0/ [Creative Commons (https://creativecommons.org/about/cclicenses/)].

Indication that the copyright holder reserves, or holds for its own use, all the rights provided by copyright law. It is not allowed to re-use the resource [NFDI4Health].

A license that is not covered by any of the other values in this list [NFDI4Health].

The license is not applicable for the resource [NFDI4Health].

It is unknown whether there is a license defining the use rights of the resource [NFDI4Health].

Type of the name which can be used to denote a person [NFDI4Health].

Type of the name which can be used to denote a group of persons or an institution/organisation [NFDI4Health].

(1) An entity with knowledge of how to access, troubleshoot, or otherwise field issues related to the resource ; (2) An entity acting as a channel for communication between groups or on behalf of a group [DataCite (https://doi.org/10.14454/3w3z-sa82), NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health].

(1) An authoritative body who brought the item into existence; (2) A group of main researchers or an organisation involved in producing the data; (3) A collective name of the authors of the resource [DataCite (https://doi.org/10.14454/3w3z-sa82), NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health].

An organization that supports (sponsors) something through some kind of financial contribution [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A private organization that supports (sponsors) something through some kind of financial contribution [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

(1) An organization taking responsibility for and initiating a study; (2) An individual, organization, group or other legal person taking responsibility for securing the arrangements to initiate and/or manage a study (including arrangements to ensure that the study design meets appropriate standards and to ensure appropriate conduct and reporting). In commercial trials, the primary sponsor is normally the main applicant for regulatory authorization to begin the study. It may or may not be the main funder [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary), NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

An organization who has agreed with the primary sponsor to take responsibility for a study [WHO (https://www.who.int/clinical-trials-registry-platform/unambiguous-trial-identification/the-universal-trial-number-(utn)), NFDI4Health].

An organization both initiating and conducting the study [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Typically refers to a group of individuals with a lab, department, or division that has a specifically defined focus of activity [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person/institution responsible for finding or gathering/collecting data under the guidelines of the author(s) or Principal Investigator (PI) [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person tasked with reviewing, enhancing, cleaning, or standardizing metadata and the associated data submitted for storage, use, and maintenance within a data centre or repository [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person (or organisation with a staff of data managers, such as a data centre) responsible for maintaining the finished resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Institution tasked with responsibility to generate/disseminate copies of the resource in either electronic or print form [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Typically, the organisation allowing the resource to be available on the internet through the provision of its hardware/software/operating support [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Typically, a person or organisation responsible for the artistry and form of a media product [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Entity that holds, archives, publishes prints, distributes, releases, issues, or produces the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Institution/organisation officially appointed by a Registration Authority to handle specific tasks within a defined area of responsibility [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A standards-setting body from which Registration Agencies obtain official recognition and guidance [DataCite (https://doi.org/10.14454/3w3z-sa82)]. 

Person or institution owning or managing property rights, including intellectual property rights over the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Designated administrator over one or more groups/teams working to produce a resource, or over one or more steps of a development process [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Any institution or group of individuals making a significant contribution to the development and/or maintenance of the resource, but whose contribution is not adequately described by any of the other values for “Role type” [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person with knowledge of how to access, troubleshoot, or otherwise field issues related to the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)]. 

A person who is responsible for the scientific and technical direction of the entire study [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

(1) A person who brought the item into existence; (2) An author of the resource [DataCite (https://doi.org/10.14454/3w3z-sa82), NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

(1) A person taking responsibility for and initiating a study; (2) An individual, organization, group or other legal person taking responsibility for securing the arrangements to initiate and/or manage a study (including arrangements to ensure that the study design meets appropriate standards and to ensure appropriate conduct and reporting). In commercial trials, the primary sponsor is normally the main applicant for regulatory authorization to begin the study. It may or may not be the main funder [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary), NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

A person who has agreed with the primary sponsor to take responsibility for a study [WHO (https://www.who.int/clinical-trials-registry-platform/unambiguous-trial-identification/the-universal-trial-number-(utn)), NFDI4Health].

A person both initiating and conducting the study [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Person/institution responsible for finding or gathering/collecting data under the guidelines of the author(s) or Principal Investigator (PI) [DataCite (https://doi.org/10.14454/3w3z-sa82)]. 

Person tasked with reviewing, enhancing, cleaning, or standardizing metadata and the associated data submitted for storage, use, and maintenance within a data centre or repository [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person (or organisation with a staff of data managers, such as a data centre) responsible for maintaining the finished resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person who oversees the details related to the publication format of the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Typically, a person or organisation responsible for the artistry and form of a media product [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person officially designated as head of project team or sub-project team instrumental in the work necessary to development of the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person officially designated as manager of a project. Project may consist of one or many project teams and sub-teams [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person on the membership list of a designated project/project team [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person without a specifically defined role in the development of the resource, but who is someone the author wishes to recognize [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A person without a specifically defined role in the development of the resource, but who is someone the author wishes to recognize [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Person or institution owning or managing property rights, including intellectual property rights over the resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Designated administrator over one or more groups/teams working to produce a resource, or over one or more steps of a development process [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An entity responsible for ensuring the comprehensive contents, versioning, and availability of the Work Package during the development of the resource. A Work Package is a recognized data product, not all of which is included in publication. The package, instead, may include notes, discarded documents, etc. [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Any person making a significant contribution to the development and/or maintenance of the resource, but whose contribution is not adequately described by any of the other values for “Role type” [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Open Researcher and Contributor ID (ORCID) provides identifiers, i.e. alphanumeric codes, to uniquely identify authors and contributors of scholarly communication; ORCID's website: https://orcid.org/ [NFDI4Health].

Research Organization Registry (ROR) provides open, sustainable, usable, and unique identifiers for every research organization in the world; ROR's website:https://ror.org/ [NFDI4Health].

Global Research Identifier Database (GRID) was an open database of unique research-related organisation identifiers. In 2021 GRID passed the torch to ROR for being the community driven research organisation identifier; GRID's website: https://www.grid.ac/ [NFDI4Health].

ISNI (International Standard Name Identifier) is an ISO standard used to uniquely identify persons and organizations; ISNI's website: http://www.isni.org/ [NFDI4Health].

Research Organization Registry (ROR) provides open, sustainable, usable, and unique identifiers for every research organization in the world; ROR's website:https://ror.org/ [NFDI4Health].

Global Research Identifier Database (GRID) was an open database of unique research-related organisation identifiers. In 2021 GRID passed the torch to ROR for being the community driven research organisation identifier; GRID's website: https://www.grid.ac/ [NFDI4Health].

ISNI (International Standard Name Identifier) is an ISO standard used to uniquely identify persons and organizations; ISNI's website: http://www.isni.org/ [NFDI4Health].

The identifier provided by the German Clinical Trials Register (DRKS) when a study is registered [NFDI4Health].

The identifier provided by the ClinicalTrials.gov when a study is registered [NFDI4Health].

The identifier provided by the ISRCTN registry when a study is registered [NFDI4Health].

The identifier provided by the European Union Drug Regulating Authorities Clinical Trials Database (EudraCT) when a study is registered [NFDI4Health].

The identifier provided by the European Databank on Medical Devices when an object is registered [NFDI4Health].

The Universal Trial Number used to facilitate the unambiguous identification of clinical trials. The UTN is not a registration number [WHO (https://www.who.int/clinical-trials-registry-platform/unambiguous-trial-identification/the-universal-trial-number-(utn))].

The identifier provided by KonsortSWD (https://www.konsortswd.de/ratswd/themen/krisen/corona/) [NFDI4Health].

The identifier provided by the MDM Portal (Medical Data Models) (https://www.medizinische-datenmodelle.de/) [NFDI4Health].

An identifier that is not covered by any of the other values in this list [NFDI4Health].

Digital Object Identifier: a character string used to uniquely identify an object. A DOI name is divided into two parts, a prefix and a suffix, separated by a slash [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Uniform Resource Locator, also known as web address, is a specific character string that constitutes a reference to a resource. The syntax is: scheme://domain:port/path?qu erystring#fragmentid [DataCite (https://doi.org/10.14454/3w3z-sa82)].

arXiv identifier: arXiv.org is a repository of preprints of scientific papers in the fields of mathematics, physics, astronomy, computer science, quantitative biology, statistics, and quantitative finance [DataCite (https://doi.org/10.14454/3w3z-sa82)].

European Article Number, now renamed International Article Number, but retaining the original acronym, is a 13-digit barcoding standard that is a superset of the original 12-digit Universal Product Code (UPC) system [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Electronic International Standard Serial Number: ISSN used to identify periodicals in electronic form (eISSN or e-ISSN) [DataCite (https://doi.org/10.14454/3w3z-sa82)].

This refers specifically to an ID in the Handle system operated by the Corporation for National Research Initiatives (CNRI) [DataCite (https://doi.org/10.14454/3w3z-sa82)].

International Standard Book Number: a unique numeric book identifier. There are 2 formats: a 10-digit ISBN format and a 13- digit ISBN [DataCite (https://doi.org/10.14454/3w3z-sa82)].

International Standard Serial Number: a unique 8-digit number used to identify a print or electronic periodical publication [DataCite (https://doi.org/10.14454/3w3z-sa82)].

International Standard Text Code: a unique “number” assigned to a textual work. An ISTC consists of 16 numbers and/or letters [DataCite (https://doi.org/10.14454/3w3z-sa82)].

The linking ISSN or ISSN-L enables collocation or linking among different media versions of a continuing resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Life Science Identifiers: a unique identifier for data in the Life Science domain. Format: urn:lsid:authority:namespace:identifier:revision [DataCite (https://doi.org/10.14454/3w3z-sa82)].

PubMed identifier: a unique number assigned to each PubMed record [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Persistent Uniform Resource Locator. A PURL has three parts: (1) a protocol, (2) a resolver address, and (3) a name [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Uniform Resource Name: a unique and persistent identifier of an electronic document. The syntax is: urn:< NID>:<NSS>. The leading urn: sequence is case-insensitive, <NID> is the namespace identifier, <NSS> is the namespace-specific string [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Permanent identifier for Web applications. Mostly used to publish vocabularies and ontologies. The letters ‘w3’ stand for “World Wide Web” [DataCite (https://doi.org/10.14454/3w3z-sa82)].

An identifier that is not covered by any of the other values in this list [NFDI4Health].

The resource B (a related resource) includes the resource A (the resource being registered in the portal) in a citation [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A includes B in a citation [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a supplement to B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is a supplement to A [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is continued by the work B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a continuation of the work B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is described by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A describes B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A has additional metadata B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

Additional metadata A for a B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A has a version (B) [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a version of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a new edition of B, where the new edition has been modified or updated [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a previous edition of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a portion of B; may be used for elements of a series [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A includes the part B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is used as a source of information by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is used as a source of information for A [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is documentation about/ explaining A; e.g. points to software documentation [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is documentation about B; e.g. points to software documentation [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is used to compile or create A [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is the result of a compile or creation event using A [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a variant or different form of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is the original form of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is identical to B, for use when there is a need to register two separate instances of the same resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is reviewed by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a review of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is a source upon which A is based [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a source upon which B is based [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is required by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A requires B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is replaced by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A replaces B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a portion of B; may be used for elements of a series [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A includes the part B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a supplement to B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is a supplement to A [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is continued by the work B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a continuation of the work B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is described by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A describes B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A has a version (B) [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a version of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a new edition of B, where the new edition has been modified or updated [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a previous edition of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a variant or different form of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is the original form of B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is identical to B, for use when there is a need to register two separate instances of the same resource [DataCite (https://doi.org/10.14454/3w3z-sa82)].

B is a source upon which A is based [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is a source upon which B is based [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A is replaced by B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

A replaces B [DataCite (https://doi.org/10.14454/3w3z-sa82)].

(1) A study that does not aim to alter study outcomes of interest; (2) A study in which the assignment of the patient to a particular therapeutic strategy is not decided in advance by a trial protocol but falls within current practice and the prescription of the medicine is clearly separated from the decision to include the patient in the study [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health].

(1) A study that aims to alter study outcomes of interest; (2) Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health].

Clinical trials with a single arm [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Participants are assigned to one of two or more groups in parallel for the duration of the study [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Participants receive one of two (or more) alternative interventions during the initial phase of the study and receive the other intervention during the second phase of the study [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Two or more interventions, each alone and in combination, are evaluated in parallel against a control group [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Groups of participants are assigned to receive interventions based on prior milestones being reached in the study, such as in some dose escalation and adaptive design studies [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

A study type that is not covered by any of the other values in this list [NFDI4Health].

The study type is unknown [NFDI4Health].

Group of individuals with specific characteristics (for example, conditions or exposures) compared to group(s) with different characteristics, but otherwise similar. A case-control study design compares two groups of subjects: those with the disease or condition under study (cases) and a very similar group of subjects who do not have the disease or condition (controls) [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary), MIABIS (https://github.com/BBMRI-ERIC/miabis)].

(1) A study in which a group or cohort of individuals is followed for a certain length of time or until a specific outcome is reached. Studies of this type incorporate the strengths of both cohort and case-control studies but eliminates a portion of the methodologic challenges inherent in both types of studies; (2) For each identified case one or more controls are selected, which are still under observation in a cohort study at the time when the case developed the disease of interest [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt)].

Single group of individuals with specific characteristics [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Characteristics of case immediately prior to disease onset (sometimes called the hazard period) compared to characteristics of same case at a prior time (that is, control period) [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Geographically defined populations, such as countries or regions within a country, compared on a variety of environmental (for example, air pollution intensity, hours of sunlight) and/or global measures not reducible to individual level characteristics (for example, healthcare system, laws or policies median income, average fat intake, disease rate) [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Studies conducted among family members, such as genetic studies within families or twin studies and studies of family environment [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary)].

Twin studies measure the contribution of genetics (as opposed to environment) to a given trait or condition of interest [MIABIS (https://github.com/BBMRI-ERIC/miabis)].

(1) Group of individuals, initially defined and composed, with common characteristics (for example, condition, birth year), who are examined or traced over a given time period; (2) Data collected over time from the same cohort of respondents. The individuals in the cohort are connected in some way or have shared some significant experience within a given period. In some cases, the samples may differ between waves but are drawn from the same cohort. Examples: birth year, disease (clinical trials), common problem (intervention studies), education, employment, family formation, participation in an event; (3) A form of longitudinal study for the analysis of risk factors following a group of people who do not have a disease, and uses correlations to determine the absolute risk of subject contraction [CT.gov (https://prsinfo.clinicaltrials.gov/definitions.html, https://www.clinicaltrials.gov/ct2/about-studies/glossary), MIABIS (https://github.com/BBMRI-ERIC/miabis), DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

A random subcohort from the overall cohort is picked and all cases (either within this random subcohort or outside) will be selected as well. Also a suitable design for the investigation of several diseases in parallel.

A cohort study for which the subjects are followed from the time of birth usually including information about gestation and follow up [MIABIS (https://github.com/BBMRI-ERIC/miabis)].

Data are collected from different samples or different groups of people from the same population at several points in time, using at least partly the same set of questions/variables. Conclusions are drawn for the population. Examples: European Social Survey (ESS), national longitudinal crime surveys [DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

Data are collected over time from, or about, the same sample of respondents. Differs from cohort data in that the selection of respondents is not based on their being connected in some way or having shared some significant experience [DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

(1) Data collected repeatedly over time to allow studying change in a population. At least some of the questions or modules are repeated over waves. Use the broad term when none of the subterms is suitable; (2) Research studies involving repeated observations of the same entity over time. In the biobank context, longitudinal studies sample a group of people in a given time period, and study them at intervals by the acquisition and analyses of data and/or samples over time [MIABIS (https://github.com/BBMRI-ERIC/miabis), DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

(1) Data collected by observing subjects within the study period, without regard to changes over time. May include more than one collection event. Analysis of cross-sectional data often consists in comparing the differences and similarities among subjects; (2) A type of observational study that involves data collection from a population, or a representative subset, at one specific point in time [MIABIS (https://github.com/BBMRI-ERIC/miabis), DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

Data are collected at one point in time to complete information collected in a previous cross-sectional study; the decision to collect follow-up data was not included in the original study design [DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

Data are collected repeatedly over time to study change in observations. These are typically "objective" measurements of phenomena that can be observed externally, as opposed to attitudes/opinions or feelings. Examples may include economic/financial indicators, natural/meteorological phenomena, vital statistics, etc. [DDI (https://ddialliance.org/Specification/DDI-CV/TimeMethod_1.2.html)].

A quality control testing study design type is where some aspect of the experiment is quality controlled for the purposes of quality assurance [MIABIS (https://github.com/BBMRI-ERIC/miabis)].

An observational study which includes an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose [NCI (GitHub - NCI-Thesaurus/thesaurus-obo-edition: OBO Library edition of NCIt), NFDI4Health]

A study type that is not covered by any of the other values in this list [NFDI4Health].

The study type is unknown [NFDI4Health].